Rutundic acid is primarily used in pharmaceutical research due to its anti-inflammatory and antioxidant properties. It has shown potential in inhibiting key enzymes involved in inflammatory pathways, making it a candidate for development in treatments for chronic inflammatory diseases such as arthritis and inflammatory bowel disease. Additionally, rutundic acid exhibits modulatory effects on cellular signaling pathways related to oxidative stress, which may contribute to its protective role in neurodegenerative conditions. It is also being investigated for its possible antidiabetic effects, as early studies suggest it can improve insulin sensitivity and glucose uptake in cell models. Due to its natural origin and low toxicity profile, it is considered a promising lead compound in the design of new therapeutic agents.